This Biotech Startup Wants to Delay Menopause by 15 Years
Menopause begins when someone’s ovaries produce far less estrogen and progesterone than they once did. This causes said ovaries to slow the release of follicles that influence one’s ability to reproduce. Though everyone hits menopause at a bit of a different pace, Beim believes she and her firm can offset the beginning of this phase by 10 to 15 years, pushing the average onset age up to 70 years old. This would both extend a patient’s fertility and hinder the health issues that coincide with the beginning of menopause, like heart disease, bone disease, and Alzheimer’s.
“If we could buy women an extra 10 to 15 years of natural endocrine function, we’re talking about a huge boost in their vitality and their wellness at a critical stage in their life,” Beim told Fortune when Celmatix’s mission became public last year. Celmatix plans on starting clinical trials of its menopause-delaying drug in 2023. The trials will begin with women undergoing chemotherapy, which is a common cause of premature menopause.
Celmatix’s drug primarily works by mimicking anti-Mullerian hormone (AMH), which ovarian follicles naturally produce to regulate the body’s reproductive functions. Patients will be able to stop taking the drug if they wish to have a baby, just like they already do with birth control. Celmatix is also working under a grant from the Bill and Melinda Gates Foundation to experiment with new non-hormonal birth control, as hormonal options come with a slew of side effects that make most contraceptives unappealing.
Healthcare options largely impacting women have long been under-researched and under-funded for reasons we won’t go into here, but Beim sees big change on the horizon. Since 2020 Celmatix has been working with multinational pharmaceutical and life sciences company Bayer, which has sunk hundreds of millions of dollars into women’s healthcare research in recent years. An increase in awareness of women’s health issues, along with the growth of “femtech” (medical technology focused on those assigned female at birth) are also helping medical professionals take their patients’ experiences more seriously.
Continue reading
Samsung Starts Rolling Out Galaxy S20 Android 11 Update on Verizon
Not only does this include the Googley Android 11 enhancements, but it also has numerous Samsung-specific changes as part of the One UI 3.0 revamp.
OnePlus Founder’s New Startup Bought the Husk of Andy Rubin’s Essential
OnePlus's cofounder recently left to start a new venture called Nothing. Currently, Nothing makes nothing, so that's a fitting name. It might make something soon now that it has purchased the husk of Andy Rubin's smartphone startup.
T-Mobile Will Start Selling Your Personal Data on April 26 Unless You Opt Out
T-Mobile will start sharing your data with third-parties and using it for targeted advertising on April 26, unless you take action to opt out.
Intel in Talks to Start Producing Automotive Chips in Just 6-9 Months
According to Intel CEO Pat Gelsinger, his company is spinning up fast to build chips for auto companies that have been impacted by the semiconductor shortage, with the idea that Intel might be able to make a difference in the medium term.